GO:0003880 protein C-terminal carboxyl O-methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003880 describes the enzymatic transfer of a methyl group to the oxygen atom of a carboxyl group at the C-terminus of a protein [1,2].
• This activity is best known for methyl-esterifying prenylated cysteine residues on Ras-related GTPases and other CAAX-box proteins [1,2,6].
• The reaction is catalyzed by prenylcysteine carboxyl methyltransferases such as STE14 in yeast and ICMT in mammals, and by leucine carboxyl methyltransferases such as LCMT-1 [1,7].
• Substrate specificity varies: some enzymes prefer farnesylated over geranylgeranylated substrates, while others act on C-terminal leucine residues [5,6].
• Loss of C-terminal methylation alters protein localization, stability, and protein-protein interactions, impacting processes such as cell signaling and vesicle trafficking [1,8].
• CRISPR knockout, point-mutation, and knock-in models are powerful tools to dissect the physiological roles of these methyltransferases [7,8].
Description
Protein C-terminal carboxyl O-methyltransferase activity (GO:0003880) is a molecular function that catalyzes the transfer of a methyl group to the oxygen atom of a carboxyl group at the C-terminus of a protein [1,2]. This modification, known as C-terminal methylation, is a post-translational event that modulates the hydrophobicity and electrostatic properties of target proteins, often influencing their membrane association and interactions with other molecules [1,2]. The activity was first characterized in the context of prenylated proteins, where the C-terminal cysteine of CAAX-box motifs is methyl-esterified following proteolytic removal of the -aaX tripeptide [1,2]. Since then, additional substrates, including C-terminal leucine residues on cytosolic polypeptides, have been identified, expanding the functional repertoire of this enzyme class. Researchers study GO:0003880 because it sits at the crossroads of signal transduction, membrane trafficking, and disease pathways, making it a compelling target for both basic and translational research [1,6,8].
protein C-terminal carboxyl O-methyltransferase activity At A Glance
| GO ID | GO:0003880 |
|---|---|
| GO term | protein C-terminal carboxyl O-methyltransferase activity |
| Ontology | molecular_function |
| Synonym | C-terminal protein carboxyl methyltransferase activity |
| Major function | Transfer of a methyl group to the oxygen atom of a C-terminal carboxyl group on a protein |
| Cofactor | S-adenosyl-L-methionine (SAM) as methyl donor (implied by methyltransferase activity) |
| Substrates | Prenylated cysteine residues (e.g., on Ras, Rho), C-terminal leucine residues on cytosolic polypeptides |
| Representative enzymes | STE14 (yeast), ICMT (mammals), LCMT-1 (leucine carboxyl methyltransferase) |
| Biological context | Post-translational modification affecting membrane localization, protein stability, and signaling |
What Is GO:0003880?
According to the Gene Ontology, GO:0003880 is defined as the catalysis of the transfer of a methyl group to the oxygen atom of a carboxyl group at the C-terminal of a protein. In simpler terms, it is an enzymatic reaction that attaches a methyl group (-CH3) to the very end of a protein, specifically onto a carboxyl group that is part of the protein's C-terminal region. This modification is a type of post-translational methylation and is distinct from methylation events that occur on lysine or arginine side chains. The reaction typically uses S-adenosyl-L-methionine (SAM) as the methyl donor, although the QuickGO definition does not explicitly name the cofactor. The activity is synonymous with C-terminal protein carboxyl methyltransferase activity.
Why Is protein C-terminal carboxyl O-methyltransferase activity Important in Cell Biology?
GO:0003880 is important because C-terminal methylation is a critical determinant of protein function, particularly for small GTPases that regulate cell growth, cytoskeletal dynamics, and vesicular transport [1,2,8]. By modifying the C-terminus, this activity can control the affinity of proteins for membranes and their ability to engage downstream effectors, thereby influencing pathways that are frequently dysregulated in cancer and other diseases [1,8]. Moreover, the enzymes that carry out this reaction are potential drug targets, and understanding their substrate specificity and regulation is essential for developing selective inhibitors [6,7].
• Regulates membrane association of Ras and Rho family GTPases, which are central to cell proliferation and migration [1,8].
• Modulates protein-protein interactions by neutralizing the negative charge of the C-terminal carboxyl group.
• Influences the stability and subcellular localization of prenylated proteins [1,6].
• Plays a role in vesicular trafficking and neuronal signaling through methylation of C-terminal leucine residues.
• Is implicated in cancer biology, as aberrant methylation of Ras-related proteins can promote tumorigenesis.
• Provides a mechanism for dynamic regulation of protein function in response to cellular signals.
• Represents a target for antiparasitic drug development, as Trypanosoma brucei encodes a prenylated-protein carboxyl methyltransferase.
• Contributes to the regulation of protein phosphatase 4 and 6 holoenzyme assembly via LCMT-1.
• Can be studied using synthetic farnesyl cysteine-containing peptide substrates for enzyme assays.
• Enables researchers to dissect post-translational modification networks using CRISPR-based genetic models [7,8].
What Happens During protein C-terminal carboxyl O-methyltransferase activity?
Substrate recognition and binding
In simple terms: The enzyme first grabs onto the target protein at its tail end.
The methyltransferase recognizes specific C-terminal sequences, often a prenylated cysteine or a leucine residue, through a substrate-binding pocket [1,2,5]. For prenylated proteins, the CAAX motif is first processed by proteases to expose the cysteine, which then becomes the methyl acceptor. In the case of leucine carboxyl methyltransferases, the enzyme binds to C-terminal leucine residues on proteins such as protein phosphatase 2A [5,7].
Methyl group transfer
In simple terms: The enzyme then hands over a methyl group to the protein's tail.
Using S-adenosyl-L-methionine (SAM) as the methyl donor, the enzyme transfers the methyl group to the oxygen atom of the C-terminal carboxyl group, forming a methyl ester [1,2]. This reaction neutralizes the negative charge of the carboxylate, which can alter the protein's hydrophobicity and membrane affinity.
Product release and functional consequences
In simple terms: After the methyl group is attached, the modified protein is released and can go do its job.
The methylated protein is released from the enzyme, and the newly formed methyl ester can affect protein localization, stability, and interactions [1,8]. For example, methylated Ras proteins exhibit increased membrane association and altered signaling capacity [1,8]. The reaction is reversible in some contexts, but the forward reaction is favored under normal cellular conditions.
Substrate specificity and enzyme diversity
In simple terms: Different enzymes prefer different protein tails.
Some methyltransferases, such as the Trypanosoma brucei enzyme, prefer farnesylated substrates over geranylgeranylated ones. Others, like LCMT-1, act on leucine residues rather than prenylated cysteines. This diversity allows for fine-tuned regulation of distinct protein subsets [5,6,7].
Key Genes Involved in GO:0003880 protein C-terminal carboxyl O-methyltransferase activity
The following genes and proteins are experimentally validated to be involved in or regulated by protein C-terminal carboxyl O-methyltransferase activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STE14 (S. cerevisiae) | Prenylcysteine carboxyl methyltransferase | First identified gene required for farnesyl cysteine C-terminal methylation |
| ICMT (human) | Prenylcysteine carboxyl methyltransferase | Mammalian ortholog of STE14; methylates Ras and Rho GTPases [1,8] |
| LCMT-1 (human) | Leucine carboxyl methyltransferase | Methylates protein phosphatase 2A and PP4/PP6 |
| LCMT-2 (human) | Leucine carboxyl methyltransferase | Related to LCMT-1; may have distinct substrate specificity |
| PP2A (human) | Protein phosphatase 2A | Substrate of LCMT-1; methylation regulates holoenzyme assembly |
| PP4 (human) | Protein phosphatase 4 | Methylated by LCMT-1; affects PP4 holoenzyme formation |
| PP6 (human) | Protein phosphatase 6 | Methylated by LCMT-1; differentially regulated |
| RhoA (human) | Small GTPase | Methylation controls RhoA activity and localization |
| Ras (human) | Small GTPase | Methylation required for membrane association and signaling [1,8] |
| CES1 (human) | Carboxylesterase 1 | Regulates RhoA methylation by hydrolyzing methyl esters |
| STE14 (C. elegans) | Prenylcysteine carboxyl methyltransferase | Model for studying methylation in development |
| PCMT (bovine brain) | Protein carboxyl methyltransferase | Partially purified from bovine brain; farnesyl cysteine specific |
| PCMT (rat liver) | Protein carboxyl methyltransferase | Identified using synthetic farnesyl cysteine peptide |
| PCMT (kidney) | Protein carboxyl methyltransferase | Functional size determined from basolateral membranes |
| TbPCMT (T. brucei) | Prenylated-protein carboxyl methyltransferase | Preferentially methylates farnesylated substrates |
| C-terminal leucine methyltransferase (bovine brain) | Leucine carboxyl methyltransferase | Methylates 36-kDa cytosolic polypeptides |
How Is protein C-terminal carboxyl O-methyltransferase activity Regulated?
The activity of protein C-terminal carboxyl O-methyltransferase is regulated at multiple levels. Substrate availability, particularly the prenylation status of target proteins, directly influences enzyme activity [1,6]. For example, farnesylated substrates are preferred by some enzymes, while geranylgeranylated substrates may be poor substrates. Additionally, the expression levels of the methyltransferases themselves can be modulated transcriptionally, although specific transcription factors have not been fully elucidated. Post-translational modifications of the enzymes, such as phosphorylation, may also affect their activity, but direct evidence is limited. In the case of LCMT-1, its ability to methylate PP4 and PP6 is differentially regulated, suggesting that additional factors control substrate selection. Carboxylesterase I can reverse RhoA methylation by hydrolyzing the methyl ester, providing a dynamic regulatory mechanism.
protein C-terminal carboxyl O-methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ICMT | Cancer (Ras-driven tumors) | ICMT knockout in cancer cell lines; xenograft models [1,8] |
| LCMT-1 | Neurodegeneration, cancer | LCMT-1 knockout mice; neuronal cell lines |
| RhoA | Cancer metastasis | RhoA point-mutant knock-in cells; invasion assays |
| TbPCMT | Sleeping sickness | T. brucei knockout; parasite viability assays |
| CES1 | Cancer, metabolic disorders | CES1 overexpression or knockout in cell lines |
Cancer
Dysregulation of C-terminal methylation is linked to cancer through its effects on Ras and Rho GTPases. Methylation of Ras proteins is required for their membrane localization and oncogenic signaling, and inhibition of ICMT has been explored as an anti-cancer strategy [1,8]. Similarly, RhoA methylation controls cell migration and invasion, processes critical for metastasis. Carboxylesterase I, which regulates RhoA methylation, may influence tumor progression.
Neurodegeneration
Protein phosphatase 2A methylation by LCMT-1 is important for neuronal function, and altered methylation has been implicated in neurodegenerative diseases such as Alzheimer's disease, although direct evidence for GO:0003880 in this context is still emerging. The presence of C-terminal leucine methyltransferase activity in bovine brain suggests a role in neuronal signaling.
Parasitic infections
Trypanosoma brucei, the causative agent of sleeping sickness, encodes a prenylated-protein carboxyl methyltransferase that is essential for its survival, making it a potential drug target. The enzyme's preference for farnesylated substrates distinguishes it from mammalian enzymes, offering a selectivity window for inhibitor development.
From protein C-terminal carboxyl O-methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ICMT affect Ras localization? | ICMT knockout cell lines (CRISPR) [1,8] |
| How does RhoA methylation regulate cell migration? | RhoA point-mutation (methylation-deficient) knock-in |
| What is the role of LCMT-1 in PP4 holoenzyme assembly? | LCMT-1 knockout or knockdown cells |
| Can TbPCMT be selectively inhibited? | T. brucei knockout and overexpression models |
| Does CES1 regulate RhoA methylation in vivo? | CES1 overexpression or knockout mouse models |
| How does C-terminal leucine methylation affect protein stability? | Tagged knock-in of leucine-methylated proteins |
How to Study the protein C-terminal carboxyl O-methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro methyltransferase assay | Enzyme activity using synthetic peptide substrates | Kinetic characterization of purified enzymes |
| Radioactive methylation assay | Incorporation of [3H]-methyl groups into proteins | Detection of activity in tissue extracts |
| Mass spectrometry | Mass shift of +14 Da on C-terminal peptides | Identification of methylated proteins in cells |
| Western blot with methylation-specific antibodies | Levels of methylated proteins | Validation of methylation changes in knockout cells |
| CRISPR knockout screens | Genes required for methylation or methylated protein function | Discovery of novel regulators [7,8] |
| Subcellular fractionation | Membrane association of methylated proteins | Assessing impact of methylation on localization [1,8] |
| Co-immunoprecipitation | Protein-protein interactions of methyltransferases | Identifying regulatory complexes |
| Enzyme-linked immunosorbent assay (ELISA) | Quantification of methylated proteins | High-throughput screening of inhibitors |
Enzymatic assays with synthetic peptides
Synthetic farnesyl cysteine-containing peptides can be used as substrates to measure methyltransferase activity in vitro, as demonstrated in rat liver membranes. This method allows precise quantification of enzyme kinetics and substrate specificity.
Radioactive methylation assays
Using [3H]-SAM as the methyl donor, the transfer of tritiated methyl groups to protein substrates can be monitored by trichloroacetic acid precipitation or gel electrophoresis [1,2]. This approach is highly sensitive and suitable for crude membrane preparations.
Mass spectrometry
Mass spectrometry can detect the addition of a methyl group (+14 Da) to the C-terminus of target proteins, providing direct evidence of methylation in vivo [5,7]. This method is particularly useful for identifying novel substrates.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes that regulate C-terminal methylation or that are required for the function of methylated proteins [7,8]. Such screens have the power to uncover novel components of the methylation pathway.
How CRISPR Can Be Used to Study GO:0003880 protein C-terminal carboxyl O-methyltransferase activity
Knockout
CRISPR knockout of methyltransferase genes such as ICMT or LCMT-1 can abolish C-terminal methylation, leading to mislocalization of substrate proteins and altered cellular phenotypes [1,7]. These models are essential for determining the physiological consequences of loss of methylation.
Point Mutation
Introducing point mutations into the catalytic domain of the methyltransferase or into the methylation acceptor site of the substrate (e.g., cysteine to serine in Ras) can dissect the specific contribution of methylation to protein function. Such models are valuable for separating methylation-dependent from independent roles.
Knock-in
Knock-in of tagged or mutant versions of methyltransferases (e.g., FLAG-tagged ICMT) allows for affinity purification and proteomic identification of interacting partners. Knock-in of methylation-deficient substrates can reveal the importance of the modification in vivo.
Overexpression
Overexpression of methyltransferases or their substrates can amplify methylation signals and facilitate biochemical detection. This approach is useful for studying enzyme kinetics and for screening inhibitors in cell-based assays.
How EDITGENE Supports protein C-terminal carboxyl O-methyltransferase activity Research
Researchers studying protein C-terminal carboxyl O-methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in methylation-dependent processes, and CRISPR-based models provide a direct route to establish such causality.
Contact EDITGENE today to design your custom CRISPR model for protein C-terminal carboxyl O-methyltransferase activity research.
Frequently Asked Questions About protein C-terminal carboxyl O-methyltransferase activity
What is protein C-terminal carboxyl O-methyltransferase activity?
It is an enzymatic activity that transfers a methyl group to the oxygen atom of a carboxyl group at the C-terminus of a protein, as defined by GO:0003880 [1,2].
What genes are involved in protein C-terminal carboxyl O-methyltransferase activity?
Key genes include STE14 in yeast, ICMT in mammals, and LCMT-1 for leucine-specific methylation [1,7].
What is the GO term for C-terminal protein carboxyl methyltransferase activity?
The Gene Ontology term is GO:0003880, officially named protein C-terminal carboxyl O-methyltransferase activity.
How is protein C-terminal carboxyl O-methyltransferase activity regulated?
It is regulated by substrate prenylation status, enzyme expression levels, and reversing enzymes such as carboxylesterase I [6,8].
What diseases are associated with protein C-terminal carboxyl O-methyltransferase activity?
Dysregulation is linked to cancer through Ras and Rho GTPases, and to parasitic infections via Trypanosoma brucei enzymes [1,6,8].
What substrates are methylated by this activity?
Prenylated cysteine residues on CAAX-box proteins and C-terminal leucine residues on cytosolic polypeptides are known substrates [1,5].
Which enzymes catalyze protein C-terminal carboxyl O-methyltransferase activity?
Prenylcysteine carboxyl methyltransferases (e.g., STE14, ICMT) and leucine carboxyl methyltransferases (e.g., LCMT-1) catalyze this reaction [1,7].
How can I study protein C-terminal carboxyl O-methyltransferase activity in the lab?
Common methods include in vitro methyltransferase assays with synthetic peptides, radioactive methylation assays, and mass spectrometry [2,5].
What is the role of LCMT-1 in protein C-terminal methylation?
LCMT-1 methylates protein phosphatase 4 and 6, differentially regulating their holoenzyme assembly.
Can CRISPR be used to study protein C-terminal carboxyl O-methyltransferase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the function of methyltransferases and their substrates [7,8].
Conclusion
Protein C-terminal carboxyl O-methyltransferase activity (GO:0003880) is a fundamental post-translational modification that controls the behavior of key signaling proteins, including Ras and Rho GTPases, as well as protein phosphatases. Its impact on membrane localization, protein stability, and interactions makes it a critical node in cellular regulation and a promising target for therapeutic intervention in cancer and parasitic diseases. Continued research using advanced CRISPR models and biochemical assays will further illuminate its mechanistic details and disease relevance.
References
- 1. Hrycyna CA et al.. 1990. Farnesyl cysteine C-terminal methyltransferase activity is dependent upon the STE14 gene product in Saccharomyces cerevisiae.. Mol Cell Biol 10(10):5071-6 PMID: 2204804
- 2. Stephenson RC et al.. 1990. Identification of a C-terminal protein carboxyl methyltransferase in rat liver membranes utilizing a synthetic farnesyl cysteine-containing peptide substrate.. J Biol Chem 265(27):16248-54 PMID: 2398053
- 3. Boivin D et al.. 1994. Functional size of C-terminal protein carboxyl methyltransferase from kidney basolateral plasma membranes.. Biochim Biophys Acta 1207(1):114-9 PMID: 8043600
- 4. Yoo BC et al.. 1998. Partial purification of protein farnesyl cysteine carboxyl methyltransferase from bovine brain.. Exp Mol Med 30(4):227-34 PMID: 9894153
- 5. Xie H et al.. 1993. Methyl esterification of C-terminal leucine residues in cytosolic 36-kDa polypeptides of bovine brain. A novel eucaryotic protein carboxyl methylation reaction.. J Biol Chem 268(18):13364-71 PMID: 8514774
- 6. Buckner FS et al.. 2002. Trypanosoma brucei prenylated-protein carboxyl methyltransferase prefers farnesylated substrates.. Biochem J 367(Pt 3):809-16 PMID: 12141948
- 7. Hwang J et al.. 2016. Leucine Carboxyl Methyltransferase 1 (LCMT-1) Methylates Protein Phosphatase 4 (PP4) and Protein Phosphatase 6 (PP6) and Differentially Regulates the Stable Formation of Different PP4 Holoenzymes.. J Biol Chem 291(40):21008-21019 PMID: 27507813
- 8. Cushman I et al.. 2013. Control of RhoA methylation by carboxylesterase I.. J Biol Chem 288(26):19177-83 PMID: 23658012
